Neuromonics

Neuromonics is a form of tinnitus treatment that uses a combination of acoustic stimulation and cognitive behavioral therapy. The treatment is designed to interact, interrupt and desensitize tinnitus disturbance for long term benefit.

History

Neuromonics was developed by Paul Davis, an Australian audiologist, in the late 1990s. The treatment was initially tested in Australia before being introduced to the United States in 2003.

Treatment

The Neuromonics treatment involves the use of a device that delivers a customized neural stimulus combined with specific music tracks. The device is worn for a few hours each day, and the treatment typically lasts for six months. The treatment aims to desensitize the patient's tinnitus perception.

Effectiveness

Several studies have shown that Neuromonics can be an effective treatment for tinnitus. A study published in the journal Ear and Hearing in 2008 found that 90% of patients experienced a significant reduction in tinnitus disturbance.

See also

• Tinnitus
• Cognitive behavioral therapy
• Acoustic stimulation

References

<references />

External links

• Official website

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia